BCAX Bicara Therapeutics Inc.
Executive Summary
An institutional cluster for Bicara Therapeutics (BCAX) shows net bearish conviction in Q3 2025: 3 sellers (including a near-exit from Point72) versus 1 passive buyer (Schwab). The selling is concentrated among active/quant funds, while the sole buyer is a passive index manager, suggesting the bearish signal is more informative. Total selling value ($1.6M) outweighs buying ($2.6M net, but driven by price appreciation, not conviction).
Key Financial Metrics
Institutional Positions
Net institutional flow: -$1.6M
▲ Buyers (1)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Schwab | ADD | +45.5% | $4.4M | $2.6M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -51.1% | $1.9M | -$320.0K |
| Two Sigma | TRIM | -29.2% | $1.2M | $255.0K |
| Point72 | NEAR_EXIT | -86.1% | $2.0M | -$1.5M |
Actionable Insight
The cluster is dominated by active/quant sellers (Point72, Two Sigma, Morgan Stanley) with a near-exit from Point72, while the sole buyer is a passive index fund. This suggests informed capital is rotating out. Monitor for further 13F filings next quarter to confirm trend; the stock may face continued selling pressure if the thesis weakens.
Key Facts
- 3 sellers vs 1 buyer in Q3 2025 institutional cluster
- Point72 near-exited 86.1% of its position (from $2.0M to $476K)
- Morgan Stanley trimmed 51.1% of its stake (from $1.9M to $1.6M)
- Two Sigma trimmed 29.2% of its position
- Only buyer was Schwab (passive index fund), adding 45.5% to $4.4M
- Net dollar change across all tracked funds: -$1.6M (sellers) vs +$2.6M (buyer, largely price-driven)
Financial Impact
3 institutional sellers reduced holdings by a net of $1.6M, while 1 passive buyer added $2.6M (mostly from price appreciation). Total tracked institutional activity: $4.2M in gross turnover.
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound or reversed since quarter-end
- Small absolute dollar amounts ($1-4M) may not be material for a $1.3B market cap stock
- Passive buying from Schwab could offset some selling pressure
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BCAX-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $20.90 awaiting T+5 | awaiting T+5 | — | — |
|
May 26, 2026
19d ago
|
Insider Cluster
| $21.58 $20.00 | ▼ −7.32% | ▼ −7.79% | — |
|
May 11, 2026
4w ago
|
8-K
| $22.92 $19.29 | ▼ −15.84% | ▼ −15.75% | — |
|
May 4, 2026
5w ago
|
Press Release
| $22.72 $22.92 | ▲ +0.88% | ▼ −2.06% | — |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $22.48 $22.72 | ▲ +1.09% | ▲ +0.69% | — |
|
Apr 20, 2026
8w ago
|
Insider Cluster
| $21.28 $23.78 | ▲ +11.75% | ▲ +8.64% | — |
|
Apr 15, 2026
8w ago
|
Insider Cluster
| $23.72 $23.63 | ▼ −0.38% | ▼ −2.02% | — |
|
Apr 15, 2026
8w ago
|
Insider Cluster
| $23.72 $23.63 | ▲ +0.38% | ▲ +2.02% | — |
|
Apr 3, 2026
10w ago
|
Press Release
| $20.85 $22.14 | ▲ +6.19% | ▲ +2.05% | — |
|
Mar 23, 2026
11w ago
|
Press Release
| $18.39 $19.04 | ▲ +3.53% | ▲ +7.10% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access